Where a company has multiple ethical concerns, the total concerns percentage counts this investment once.
The average total concerns of all funds of the same risk profile is weighted by the funds' investment values.
The average total concerns of all managed aggressive funds is 12.02%.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
L'Oréal is a personal care company and cosmetics company concentrating on hair colour, skin care, sun protection, make-up, perfume, and hair care. The company states that its products are sold in countries where animal testing of cosmetic products is required by law.
Where the actions of companies have violated global standards on human rights and freedoms including customary rights of indigenous people.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. Thermo Fisher DNA testing kits have been linked to surveillance and discriminatory purposes by the legal authorities in Xinjiang (a region of China) for monitoring and tracking the Muslim Uyghur ethnic group and other minorities. Evidence shows Thermo Fisher Scientific continues to supply DNA sequencing products to the Xinjiang region, despite the company announcing it would halt sales to the region in 2019.
The Fund targets a portfolio of global companies with high total return potential and high ESG factor scores. The Fund’s investment objective is to outperform the MSCI World (Net) Index in New Zealand dollars on a rolling three-year basis.
| Value | $86.9M NZD |
| Period of data report | 31st Dec. 2024 |
| Fund started | 9th July 2021 |
| Total annual fund fees | 1.14% |
| Total performance based fees | 0.0% |
| Manager's basic fee | 1.02% |
| Other management and administration charges | 0.12% |
| Total other charges | 0.0 |
| Total other charges currency | NZD |
|
Matthew Goodson |
Currently: Managing Director (11 years, 7 months)
|
|
Paul Harrison |
Currently: Managing Director (11 years, 7 months)
|
|
Paul Turnbull |
Currently: Chief Investment Officer (5 years, 7 months)
|
|
Greg Fleming |
Currently: Head of Global Diversified Funds (3 years, 9 months)
|
|
Bevan Graham |
Currently: Economist (3 years, 10 months)
|
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.
| Year | Market Average | Fund Annual Return |
|---|---|---|
| 2024 | 14.61% | 24.0% |
| 2023 | -4.85% | 2.37% |
The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
Microsoft Corporation
United States International Equities
Sap Se
Germany International Equities
Visa Inc-Class A Shares
United States International Equities
Alphabet Inc Class A
United States International Equities
Procter and Gamble Co/The
United States International Equities
AON PLC
United States International Equities
L'Oreal SA
France International Equities
Accenture PLC
United States International Equities
Cme Group Inc
United States International Equities
Intercontinental Exchange Inc
United States International Equities
| Type | Target | Actual |
|---|---|---|
| Cash and Cash Equivalents | 0.0% | 2.03% |
| New Zealand Fixed Interest | 0.0% | 0.0% |
| International Fixed Interest | 0.0% | 0.0% |
| Australasian Equities | 0.0% | 0.0% |
| International Equities | 100.0% | 97.97% |
| Listed Properties | 0.0% | 0.0% |
| Unlisted Properties | 0.0% | 0.0% |
| Other | 0.0% | 0.0% |
| Commodities | 0.0% | 0.0% |
How the money in this fund is invested by asset type.
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
This data is compiled by Mindful Money from the fund information and portfolios
that each
fund has
filed with the Disclose register to 30th Sept. 2024 and Mindful Money
analysis of funds within those portfolios. The list of companies of concern has
been drawn from ratings agencies and public sources, including the Norwegian
Sovereign Fund, NZ Super Fund, Sustainalytics and research organisations.
Please note that companies may breach more than one of these areas of
concern.
The listing of companies of concern is based on definitions used in Mindful Money's
methodology. These definitions may
be different from the exclusions policy and definitions applied by the fund provider.
Mindful Money uses the term Mindful Funds as our standard
for ethical investment and responsible investment. This does not imply that
other funds are unethical or that the fund providers that do not meet these
standards are unethical providers.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
L'Oréal is a personal care company and cosmetics company concentrating on hair colour, skin care, sun protection, make-up, perfume, and hair care. The company states that its products are sold in countries where animal testing of cosmetic products is required by law.
Where the actions of companies have violated global standards on human rights and freedoms including customary rights of indigenous people.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. Thermo Fisher DNA testing kits have been linked to surveillance and discriminatory purposes by the legal authorities in Xinjiang (a region of China) for monitoring and tracking the Muslim Uyghur ethnic group and other minorities. Evidence shows Thermo Fisher Scientific continues to supply DNA sequencing products to the Xinjiang region, despite the company announcing it would halt sales to the region in 2019.
The Fund targets a portfolio of global companies with high total return potential and high ESG factor scores. The Fund’s investment objective is to outperform the MSCI World (Net) Index in New Zealand dollars on a rolling three-year basis.
| Value | $86.9M NZD |
| Period of data report | 31st Dec. 2024 |
| Fund started | 9th July 2021 |
| Total annual fund fees | 1.14% |
| Total performance based fees | 0.0% |
| Manager's basic fee | 1.02% |
| Other management and administration charges | 0.12% |
| Total other charges | 0.0 |
| Total other charges currency | NZD |
|
Matthew Goodson |
Currently: Managing Director (11 years, 7 months)
|
|
Paul Harrison |
Currently: Managing Director (11 years, 7 months)
|
|
Paul Turnbull |
Currently: Chief Investment Officer (5 years, 7 months)
|
|
Greg Fleming |
Currently: Head of Global Diversified Funds (3 years, 9 months)
|
|
Bevan Graham |
Currently: Economist (3 years, 10 months)
|
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.
| Year | Market Average | Fund Annual Return |
|---|---|---|
| 2024 | 14.61% | 24.0% |
| 2023 | -4.85% | 2.37% |
The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
Microsoft Corporation
United States International Equities
Sap Se
Germany International Equities
Visa Inc-Class A Shares
United States International Equities
Alphabet Inc Class A
United States International Equities
Procter and Gamble Co/The
United States International Equities
AON PLC
United States International Equities
L'Oreal SA
France International Equities
Accenture PLC
United States International Equities
Cme Group Inc
United States International Equities
Intercontinental Exchange Inc
United States International Equities
| Type | Target | Actual |
|---|---|---|
| Cash and Cash Equivalents | 0.0% | 2.03% |
| New Zealand Fixed Interest | 0.0% | 0.0% |
| International Fixed Interest | 0.0% | 0.0% |
| Australasian Equities | 0.0% | 0.0% |
| International Equities | 100.0% | 97.97% |
| Listed Properties | 0.0% | 0.0% |
| Unlisted Properties | 0.0% | 0.0% |
| Other | 0.0% | 0.0% |
| Commodities | 0.0% | 0.0% |
How the money in this fund is invested by asset type.
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st Dec. 2024.
